Stem Cell-Based Therapy to Produce GDNF Found Safe in Human Trial

Share This Story, Choose Your Platform!

Stem cells engineered to mature into nerve-supporting cells that produce GDNF — a key factor for motor neuron survival — were safely delivered into the spinal cord of people with amyotrophic lateral sclerosis (ALS), according to data from a Phase 1/2a clinical trial. Read more…